Zepbound sales keep soaring, even as weight loss drug growth slows
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s ...
AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China
Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...
Toyota likely to post second straight profit drop as sales growth cools
Japan's Toyota Motor is expected to post its second consecutive quarterly profit drop when it reports third-quarter earnings ...
Wegovy sales double to boost Novo Nordisk's fourth quarter as growth set to slow
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...
Chipotle assesses fallout from Mexico tariffs, forecasts tepid annual sales growth
Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...
IBM Gives Long-Term Sales Growth Outlook That Tops Expectations
International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...
Novo Nordisk Expects Slowing Sales Growth This Year
The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...
Novartis Expects Further Profit, Sales Growth Despite Competition Threat
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Gilead: Strong Sales Growth Remains With Veklury And Beyond
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Exclusive: Sales at Small Businesses Are Finally Starting to Grow Again
New data from the accounting platform Xero should give American entrepreneurs one more reason to be optimistic about 2025.
Seeking Alpha on MSN23h
Veralto targets low to mid-single-digit core sales growth in 2025 with $3.60–$3.70 EPS guidance
Veralto Corporation delivered all-time high annual sales of $5.2 billion in 2024, with 3.7% core sales growth and an adjusted earnings per share increase of 11% to $3.54. Free cash flow generation ...
Yum Brands Projects Stronger Sales Growth This Year
Fast-food restaurant owner Yum Brands is expecting stronger sales growth this year after it moves past challenges in its Middle East markets.